218 related articles for article (PubMed ID: 17938634)
1. Independent protein-profiling studies show a decrease in apolipoprotein A1 levels in schizophrenia CSF, brain and peripheral tissues.
Huang JT; Wang L; Prabakaran S; Wengenroth M; Lockstone HE; Koethe D; Gerth CW; Gross S; Schreiber D; Lilley K; Wayland M; Oxley D; Leweke FM; Bahn S
Mol Psychiatry; 2008 Dec; 13(12):1118-28. PubMed ID: 17938634
[TBL] [Abstract][Full Text] [Related]
2. 2-D DIGE analysis of liver and red blood cells provides further evidence for oxidative stress in schizophrenia.
Prabakaran S; Wengenroth M; Lockstone HE; Lilley K; Leweke FM; Bahn S
J Proteome Res; 2007 Jan; 6(1):141-9. PubMed ID: 17203958
[TBL] [Abstract][Full Text] [Related]
3. Proteome analysis of the thalamus and cerebrospinal fluid reveals glycolysis dysfunction and potential biomarkers candidates for schizophrenia.
Martins-de-Souza D; Maccarrone G; Wobrock T; Zerr I; Gormanns P; Reckow S; Falkai P; Schmitt A; Turck CW
J Psychiatr Res; 2010 Dec; 44(16):1176-89. PubMed ID: 20471030
[TBL] [Abstract][Full Text] [Related]
4. CSF proteome analysis in clinically isolated syndrome (CIS): candidate markers for conversion to definite multiple sclerosis.
Tumani H; Lehmensiek V; Rau D; Guttmann I; Tauscher G; Mogel H; Palm C; Hirt V; Suessmuth SD; Sapunova-Meier I; Ludolph AC; Brettschneider J
Neurosci Lett; 2009 Mar; 452(2):214-7. PubMed ID: 19383442
[TBL] [Abstract][Full Text] [Related]
5. Expression profiling of fibroblasts identifies cell cycle abnormalities in schizophrenia.
Wang L; Lockstone HE; Guest PC; Levin Y; Palotás A; Pietsch S; Schwarz E; Rahmoune H; Harris LW; Ma D; Bahn S
J Proteome Res; 2010 Jan; 9(1):521-7. PubMed ID: 19916557
[TBL] [Abstract][Full Text] [Related]
6. Proteomic analysis of the cerebrospinal fluid of patients with schizophrenia.
Jiang L; Lindpaintner K; Li HF; Gu NF; Langen H; He L; Fountoulakis M
Amino Acids; 2003 Jul; 25(1):49-57. PubMed ID: 12836058
[TBL] [Abstract][Full Text] [Related]
7. The apolipoprotein A-I level is downregulated in the granulosa cells of patients with polycystic ovary syndrome and affects steroidogenesis.
Choi DH; Lee WS; Won M; Park M; Park HO; Kim E; Lee KA; Bae J
J Proteome Res; 2010 Sep; 9(9):4329-36. PubMed ID: 20426491
[TBL] [Abstract][Full Text] [Related]
8. Global proteomic profiling reveals altered proteomic signature in schizophrenia serum.
Levin Y; Wang L; Schwarz E; Koethe D; Leweke FM; Bahn S
Mol Psychiatry; 2010 Nov; 15(11):1088-100. PubMed ID: 19546861
[TBL] [Abstract][Full Text] [Related]
9. Proteomic identification of serum biomarkers for head and neck cancer surveillance.
Gourin CG; Zhi W; Adam BL
Laryngoscope; 2009 Jul; 119(7):1291-302. PubMed ID: 19444892
[TBL] [Abstract][Full Text] [Related]
10. High throughput lipidomic profiling of schizophrenia and bipolar disorder brain tissue reveals alterations of free fatty acids, phosphatidylcholines, and ceramides.
Schwarz E; Prabakaran S; Whitfield P; Major H; Leweke FM; Koethe D; McKenna P; Bahn S
J Proteome Res; 2008 Oct; 7(10):4266-77. PubMed ID: 18778095
[TBL] [Abstract][Full Text] [Related]
11. Different apolipoprotein E, apolipoprotein A1 and prostaglandin-H2 D-isomerase levels in cerebrospinal fluid of schizophrenia patients and healthy controls.
Martins-De-Souza D; Wobrock T; Zerr I; Schmitt A; Gawinecka J; Schneider-Axmann T; Falkai P; Turck CW
World J Biol Psychiatry; 2010 Aug; 11(5):719-28. PubMed ID: 20446881
[TBL] [Abstract][Full Text] [Related]
12. Proteomic profiling of human retinal and choroidal endothelial cells reveals molecular heterogeneity related to tissue of origin.
Zamora DO; Riviere M; Choi D; Pan Y; Planck SR; Rosenbaum JT; David LL; Smith JR
Mol Vis; 2007 Oct; 13():2058-65. PubMed ID: 18079679
[TBL] [Abstract][Full Text] [Related]
13. Proteomic toolbox for autoimmunity research.
Wu T; Mohan C
Autoimmun Rev; 2009 Jun; 8(7):595-8. PubMed ID: 19393208
[TBL] [Abstract][Full Text] [Related]
14. Impaired glycolytic response in peripheral blood mononuclear cells of first-onset antipsychotic-naive schizophrenia patients.
Herberth M; Koethe D; Cheng TM; Krzyszton ND; Schoeffmann S; Guest PC; Rahmoune H; Harris LW; Kranaster L; Leweke FM; Bahn S
Mol Psychiatry; 2011 Aug; 16(8):848-59. PubMed ID: 20585325
[TBL] [Abstract][Full Text] [Related]
15. Altered levels of acute phase proteins in the plasma of patients with schizophrenia.
Yang Y; Wan C; Li H; Zhu H; La Y; Xi Z; Chen Y; Jiang L; Feng G; He L
Anal Chem; 2006 Jun; 78(11):3571-6. PubMed ID: 16737209
[TBL] [Abstract][Full Text] [Related]
16. 2-D DIGE analysis implicates cytoskeletal abnormalities in psychiatric disease.
English JA; Dicker P; Föcking M; Dunn MJ; Cotter DR
Proteomics; 2009 Jun; 9(12):3368-82. PubMed ID: 19562803
[TBL] [Abstract][Full Text] [Related]
17. Identification of differentially displayed proteins in cerebrospinal fluid of Parkinson's disease patients: a proteomic approach.
Sinha A; Srivastava N; Singh S; Singh AK; Bhushan S; Shukla R; Singh MP
Clin Chim Acta; 2009 Feb; 400(1-2):14-20. PubMed ID: 18977210
[TBL] [Abstract][Full Text] [Related]
18. Preliminary analysis of cerebrospinal fluid proteome in patients with neurocysticercosis.
Tian XJ; Li JY; Huang Y; Xue YP
Chin Med J (Engl); 2009 May; 122(9):1003-8. PubMed ID: 19493432
[TBL] [Abstract][Full Text] [Related]
19. Extravasation of plasma proteins can confound interpretation of proteomic studies of brain: a lesson from apo A-I in mesial temporal lobe epilepsy.
Yang JW; Czech T; Gelpi E; Lubec G
Brain Res Mol Brain Res; 2005 Oct; 139(2):348-56. PubMed ID: 16095751
[TBL] [Abstract][Full Text] [Related]
20. A proteome analysis of the anterior cingulate cortex gray matter in schizophrenia.
Clark D; Dedova I; Cordwell S; Matsumoto I
Mol Psychiatry; 2006 May; 11(5):459-70, 423. PubMed ID: 16491132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
